These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Immunopathogenesis of glomerulonephritis--new data on the clinical and experimental studies]. Krzymański M Przegl Lek; 1992; 49(1-2):10-2. PubMed ID: 1454997 [No Abstract] [Full Text] [Related]
5. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens. van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800 [No Abstract] [Full Text] [Related]
6. Membranous nephropathy. Insights from Heymann nephritis. Cavallo T Am J Pathol; 1994 Apr; 144(4):651-8. PubMed ID: 8160766 [No Abstract] [Full Text] [Related]
7. Role of C5b-9 in experimental membranous nephropathy. Couser WG; Schulze M; Pruchno CJ Nephrol Dial Transplant; 1992; 7 Suppl 1():25-31. PubMed ID: 1337179 [No Abstract] [Full Text] [Related]
9. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis. Makker SP; Tramontano A J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232 [TBL] [Abstract][Full Text] [Related]
10. Molecular aspects of immune deposit formation in Heymann nephritis. Kerjaschki D Nephrol Dial Transplant; 1992; 7 Suppl 1():16-20. PubMed ID: 1283449 [No Abstract] [Full Text] [Related]